Kairos Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -40 | 120 | -40 | |
EBITDA | -1,366 | -1,614 | -1,325 | -1,358 |
EBIT | -1,388 | -1,654 | -1,365 | -1,398 |
Net Income | -1,388 | -1,654 | -1,365 | -1,398 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,012 | -1,036 | -1,084 | -838 |
Cash | 2,626 | 3,675 | 4,491 | 5,575 |
Basic Shares | 3,060 | 3,001 | 2,632 | 2,886 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -160 | -160 | -160 | |
EBITDA | -5,287 | -1,584 | -1,554 | -411 |
EBIT | -5,447 | -1,744 | -1,714 | -571 |
Net Income | -5,447 | -2,603 | -1,812 | -1,050 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,441 | -3,955 | 81 | -353 |
Cash | 4,491 | 1,272 | 93 | 437 |
Basic Shares | 2,632 | 1,622 | 1,483 | 1,462 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.06 |
2026-03-31 | -$0.56 |
2025-12-31 | -$0.07 |
2025-09-30 | -$0.07 |